Funded Scientific Research Projects

In vitro generation of 34S-labelled steroid sulfates as reference material
Dr. A. KEILER and Dr. THIEME / Institute of Doping Analysis & Sports Biochemistry Dresden, Germany

In vivo administration of EPO Biosimilars with low molecular weight: How to improve detection by anti-doping laboratories
Dr. A. MARCHAND and Dr. ZHOU / AFLD, France

Metabolism and detection of ghrelin and new ghrelin mimetics
Prof. M. THEVIS, Dr. THOMAS / German Sport University Cologne, Germany

Detection of Follistatin-doping in urine and blood
Dr. C. REICHEL, Dr. GMEINER / Seibersdorf Labor GmbH, Austria

Detection criteria of EPO-Fc for TD2014EPO
Dr. C. REICHEL, Dr. GMEINER / Seibersdorf Labor GmbH, Austria

Novel strategy for the detection of new long term AAS metabolites by low energy EI GC-QTOF
Dr. M. POLET, Prof. VAN EENOO / University Ghent, Belgium

Production of a Certified Reference Material of Boldenone and Formestane to support GC-C-IRMS
Dr. P. ARMISHAW / MNI, Commonwealth of Australia

Insulins and doping: How long can we detect them in blood and urine?
Dr. K DEVENTER et al. / Ghent University, Belgium

Storage gene signature from the single red cell transcriptome analysis
Prof. J-T. CHI and Dr. ROBACK / Duke Medical Center, US

Determination of sensitivity of detection of hGH doping with hGH Biomarkers Test
Prof. T. KUURANNE / Laboratoire Suisse d’Analyse du Dopage (LAD), Switzerland

Determination of sensitivity of detection of hGH doping with hGH Biomarkers Test
Prof. M. THEVIS, Dr. A. THOMAS  / Institute of Biochemistry - German Sport University, Cologne, Germany

Confirming the synthetic origin of perdnisolone/prednisone by GC-C-IRMS
Prof. X. de la TORRE, Prof. BOTRÈ / Federazione Medico Sportiva Italiana, Italy

Factors affecting pharmacokinetics of inhaled salbutamol in athletes: Application of 4O sulfate metabolite analysis to improve predictive value of AAFs
Dr. M. HOSTRUP et al / University of Copenhagen, Denmark

Thyroid hormones in sport: Use or abuse?
Prof. X. de la TORRE et al / Federazione Medico Sportiva Italiana, Italy

Markers to reduce the effect of plasma volume variance on the Athlete Biological Passport during the two-hour period after exercise
Mr. Marc VOUILLAMOZ et al.

Determination of trimetoquinol in human urine after oral administration of trimetoquinol hydrochloride hydrate by liquid-chromatography-mass spectrometry
Dr. M. OKANO / Anti-Doping Laboratory, Tokyo, Japan

Steroid Profile: Differentiating testosterone administration from (simultaneous) ethanol consumption. Evaluation of newly developed Markers (Acronym: SPOL)
Dr J. POZO et al / IMIM Hospital del Mar, Spain

A multi-parametric approach to remove the influence of plasma volume on the ABP during a UCI cycling stage race
Dr. L. LEWIS et al. / University of Western Australia

Implications of RNA-seq in the detection of anabolic steroid use and harnessing of the molecular mechanism of muscle memory
Dr. F. PIGOZZI et al. / University of Rome “Foro Italico”, Italy

On-line multidimensional GC as clean-up step for IRMS and quadrupole MS measurements of endogenous anabolic steroids in urine
Dr. A. CASILLI et al. / Brazilian Doping Control Laboratory, Brazil

Phase-II metabolites as target biomarkers in doping analysis: Generation of reference materials and methods optimization
Dr. M. K. PARR et al. / Freie Universität Berlin, Germany & Laboratorio Antidoping FMSI, Rome, Italy

Detection of rhEPO microdosing and small-volume blood transfusion
Dr. N. NORDSBORG et al. / University of Copenhagen, Denmark

Identification of new metabolites of peptide-derived drugs using a novel Isotope-labeled Reporter Ion Detection strategy
Prof. M. THEVIS / German Sport University, Cologne

Probing for new long-term metabolites of Trenbolone by Hydrogen Isotope ration mass spectrometry
Prof. M. THEVIS / German Sport University, Cologne

Novel Biomarkers in recombinant human growth hormone detection. LC-MRM-MS Method for fibronectin quantification in antidoping routine
Dr. G. REVERTER / Fundació IMIM, Spain

Targeting recombinant EPO by LC-MS analysis if intact glycopeptide
Prof. O. JENSEN, Dr. G. SANMARTIN / University of Southern Denmark, Denmark; Pompeu Fabra University, Barcelona, Spain

Development of a Samll Peptide, 2 kDa mixed standard
Dr. C. GOEBEL / National Measurement Institute, Australia

Implementation of ultra-high performance supercritical fluid chromatography for screening and confirmation analysis
Dr. C. GOEBEL / National Measurement Institute, Australia

The synthesis and certification of three human metabolites of 7-methyl19-nortestosterone (MENT)
Dr. S. DAVIES / National Measurement Institute, Australia

Systematic examination of supplement products available in the market in order to target and substance standard development
Dr. C. GOEBEL / National Measurement Institute, Australia

Expanding the use of dried blood sports in doping controls to peptidic drugs of lower and higher molecular mass
Prof. M. THEVIS/ German Sport University, Cologne

Markers of erythropoiesis stimulating agents use and hypoxia
N. NORDSBORG et al. / University of Copenhagen, Denmark

Selection of the most appropriate markers of SARMs misuse.  The role of physiological and environmental factors
Dr. M. MAZZARINO and Prof. F. BOTRÈ / Federazione Medico Sportiva Italiana, Italy 

Addition of 19-Norandrosterone in a new certified reference material for human urinary steroids
Dr. P. ARMISHAW and Dr. J. MURBY / Commonwealth of Australia, Australia

Origin production of 19-norandrosterone in human urine samples and doping analysis
X. DE LA TORRE et al.  / Federazione Medico Sportiva Italiana, Italy

Reliable assay for rapid detection of potentially unknown erythropoietin mimetics chemically unrelated to endogenous hormone in biological samples
Dr. B. STRUKELJ, Dr. J. DVORSAK / University of Ljubljana, Slovenia

Clinical trial on the effects of tramadol and paracetamol on physical cognitive and brain performance during cycling
Dr. D. SANABRIA LUCENA / University of Granada, UK

Improving Detection of Endogenous Anabolic Steroids misuse by measuring endogenous Sulfate Metabolite (IDEASS)
Dr. R. VENTURA et al. / Fundacio IMIM, Spain

Application of athlete’s performance passport for doping control
Dr. S. ILJUKOV and Prof. S. BERMON / Research Institute for Olympic Sports, Finland

Development of a multiplexed detection assay for PEGylated proteins in doping control samples
Dr. M. THEVIS / Center for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Germany

Ultra-Sensitive Mass Spectrometric Detection of a rEPO Specific O-glycopeptide as an Unambiguous Proof of Doping—Follow-up (GOpep2)
Dr. J. PASCUAL, Dr. J. SEGURA / Fundacio IMIM (FIMIM), Spain

Azole antifungals. Confounding factors or modulators
Dr. M. MAZZARINO / Federazione Medico Sportiva

Analysis of doping control samples using SFC-MS
Prof. D. COWAN et al. / University of Southern Denmark, Denmark)

An evaluation study of stability and robustness for implementing supercritical fluid chromatography - mass spectrometry in the anti-doping field
Dr. T.KUURANE et al. / Swiss Laboratory for Doping Analyses & Laboratory of Analytical Sciences

Long-Term changes in human skeletal muscles after anabolic steroid administration
P. AAGAARD et al. / University of Southern Denmark, Denmark

Unequivocal detection of AAV-mediated gene doping by pan-AAV immunological profiling
Drs. G. RONZITTI and  F. BOSCH / France and Spain

Using DNA Typing and Erythrocyte Microparticle analysis to detect blood doping – a transfusion study
S. VOSS et al. / Anti-Doping Lab, Qatar

Detection of autologous transfusion from refrigerated or cryopreserved blood by characterization of RBC and micro particles
Dr. A. MARCHAND et al. / France

Monitoring of endogenous steroids in female serum
Prof. M. SAUGY et al  / RED, University of Lausanne, Switzerland

Enhanced urinary stability and detection window of peptide hormones and growth factors by dried urine microsampling
Laura MERCOLINI et al / University of Bologna, Delft University of Technology

Detection of EPO and evaluation of CD71 expression from a dried blood spot following rEPO administration
D. EICHNER et al / SMRTL, Salt Lake City, Utah, USA

Gene doping detection by next generation sequencing
Dr. H. HAISMA et al. / University of Groningen, The Netherlands

Establishing doping-related reference distributions for cobalt in human urine and Reference values for cobalt in serum and urine after cobalamin (vitamin B12) administration
Dr. C. REICHEL et al. / Seibersdorf Labor GmbH, Austria

Evaluation of the Athlete Steroidal Passport – Confounding Factors and Sport Specific Features in Swedish and Norwegian Athletes
Dr. J. SCHULZE et al. / Karolinska Institutet, Sweden

Detection of growth promoting peptide doping
Dr. L. ELSTRÖM et al. / Karolinska Institutet, Sweden

EPO gene doping test: Ongoing improvement and implementation in WADA-accredited laboratories
Dr. A. BAOUTINA et al. / Commonwealth of Australia, Department of Industry, Innovation and Science, National Measurement Institute (NMI), Australia

Chemical derivatization of intact phase II metabolites of AASs for confirmatory purposes
Dr. I. ANGELIS et al. / Olympic Athletic Center of Athens, Greece

Detection and characterization of new long term steroid metabolites by MRM GC-CI-MS/MS
Dr. M. POLET et al. / University Ghent, Belgium

Investigation of iron injection impact on iron metabolism biomarkers to detect blood transfusion
Dr. N. LEUENBERGER et al. / Swiss Laboratory for Doping Analyses, Switzerland

Immunorecognition of specific markers of blood storage. Customization and testing of already developed antibodies. (Acronym: Hemab2)
A. PASCUAL et al. / Fundació IMIM, Spain

The GH-2004 project: Investigation of pre-analytical effects of freeze-thaw cycles on the measurement of IGF-1 and P-III NP in human serumn
R.  HOLT et al. / University of Southampton, UK

Quantification of synthetic glucocorticoids in dried blood spot samples for in-competition sports drug testing
M.  THEVIS et al. / German Sport University Cologne, Germany

Development of DNA Aptamers Against Growth Hormone-Releasing Peptides for Detection in Serum and Mass Spectral Analyses
J.  BRUNO / Operational Technologies Corporation, USA

Small RNA transcriptome as novel approaches to detect autologous blood transfusion
J.T.  CHI et al. / Duke University, USA

Simplifying the sample preparation for routine IRMS analysis using immunoaffinity purification
M.  THEVIS et al. / German Sport University Cologne, Germany

Validation of a novel test for Autologous Blood Transfusion - Detection limits and biased for genetic variation
C. MALM et al. / ProTest Diagnostics AB, Sweden

Engineering bacterial arylsulfatases for high activity towards alpha-configured steroid sulfates: New mutant enzymes to improve doping control
M. McLEOD et al. / Australian National University, Australia

Athlete Biological Passport, Steroids and Pain Killers – Does hydroxysteroid dehydrogenase inhibition by nonsteroidal anti-inflammatory drugs alter the steroid profile?
Dr. F. BOTRE, et al. / Federazione Medico Sportiva Italiana, Italy

Studies on intra-articular and peri-articular administrations of glucocorticoids
Dr. R. VENTURA, Dr. X. MATABOSCH / Fundació IMIM, Spain

Terbutaline doping control using enantioselective urine assays
Dr. G. JACOBSON et al. / University of Tasmania, Australia; University of Copenhagen

Improving the Athlete Biological Passport (2): longitudinal evaluation of isotope ratio mass spectrometric data
Dr. X. DE LA TORRE, Dr. D. JARDINES / Federazione Medico Sportiva Italiana, Rome Doping Control Laboratory, Italy

Development of an analytical method for the detection of the misuse of the peptidic substance thymosin ß-4 (TB4) as doping substance
W. SCHANZER / German Sport University, Germany

Expanding the testing capability of immunopurification assisted analytical methods for peptides > 2kDa by means of mass spectrometry
M. THEVIS et al. / German Sport University, Germany

Simplifying and expanding the screening for peptides < 2 kDa by means of liquid chromatography mass spectrometry
M. THEVIS et al. / German Sport University, Germany

Fc-based fusion proteins in sports drug testing: Detecting GDF15/Fc and the myostatin inhibitor ActRIIB-Fc by proteomic approaches
M. THEVIS et al. / German Sport University, Germany

An in vitro study on the biotransformation pathways of vaptans. Selection of the most appropriate markers of misuse
M.  MAZZARINO et al. / Federazione  Medico  Sportiva  Italiana (FMSI), Italy

Circulating myomiRs as markers of myogenic precursor abundance
P. COSTELLI / University of Turin, Italy

Detection of Growth hormone by LC-MS Analysis
G. SANMARTIN / University Pompeu Fabra, Spain

Synthesis of peptide hormone metabolites for inclusion LC-MS/MS detection methods
C. REICHEL / Seibersdorf Labor GmbH, Austria

Production and Certification of a Replacement Certified Reference Material for Human Urinary Steroids to ensure Quality of Longitudinal Profiling Data
J. MURBY / National Measurement Institute, Australia

Sewer based tracing of doping use by amateur athletes
P. de VOOGT / University of Amsterdam, Netherlands

A Pilot study: Steroid profiling in saliva, route of administration study and influence on salivary parameters
P. VAN EENOO et al. / University of Ghent, Belgium

Implementation of a high performance strategy for the detection and identification of small peptide hormones
C. BUISSON/ AFLD, France

Improving detection of anabolic steroids: New screening based on the direct analysis of phase II metabolites using LC-Q-HRMS
R. VENTURA et al. / Fundació IMIM, Spain

Impact of cryopreservation on red blood cell function - New strategies to detect autologous blood doping
M. GRAU et al. / German Sport University, Germany

Dose-response effect of alcohol ingestion on steroid profile: Gender and ethnic aspects (Acronym: profethyl2)
R. de la TORRE et al. / IMIM, Spain

Detecting Autologous Blood Transfusions Using Dielectrophoretic Spectroscopy
Z. GAGNON / Johns Hopkins University, USA

Tramadol and sport: Effects on physical and sustained attention performance during cycling exercise
D. SANABRIA et al. / University of Granada, Spain

Improved detection of Oral-Turinabol structure identification and elimination of metabolites and generation of reference material
M.PARR et al. / Freie Universität Berlin, Germany

Ultra-Sensitive Mass Spectrometric Detection of a rEPO Specific O-glycopeptide as an Unambiguous Proof of Doping Follow-up (GOpep2)
J. PASCUAL et al. / fundacio IMIM (FIMIM), Spain

Verification of a stable blood storage small RNA biomarker signature in subjects after autologous blood doping
M.PFAFFL et al. / Technical University Munich, Germany

Improving the Athlete Biological Passport: Inclusion of specific and long term biomarkers
Dr. X. de la TORRE et al. / Federazione Medico Sportiva Italiana, Italy

Evaluating the use of massively parallel sequencing technology for gene doping testing
Dr. BAOUTINA et al. / Commonwealth of Australia, (NMI) Australia

BIs-Conjugates in the Endogenous Profile of Steroids (BICEPS)
O. POZO et al. / IMIM, Spain

Ecdysteroids as non-conventional anabolic agents: Pharmacodynamics, pharmacokinetics, and detection of ecdysterone
M.PARR et al. / Freie Universität Berlin, Germany

Necessary Steps for the Application of an Integrative “Omics” Solution to the Detection of Recombinant Human Erythropoietin
Dr. Y. PITSILADIS &  Dr. FRIEDMAN / University of Brighton, UK & UC-San Diego, USA

Single vs. combinatory effects of non-prohibited Beta-2 agonists at threshold doses on skeletal muscle metabolism and endurance performance
Dr. M. ZUEGEL et al / University of Ulm, Germany

Novel molecular biomarkers for detection of autologous blood transfusion in sport: Fetal hemoglobin and microRNAs
F. MANFREDINI et al. / University of Ferrara, Italy

Metabolism of exogenous testosterone in UGT2B17 del/del genotype
M. THEVIS et al. / German Sport university, Cologne, Germany

Metabolism of anabolic steroids by adrenocortical cytochromes P450– search for new long-term doping markers
R. BERNHARDT et al. / Universität des Saarlandes, Germany

Erythropoietin Receptor Beads: Comprehensive isolation and analysis of erythropoiesis-stimulating agents (ESAs)
M. THEVIS et al. / German Sport university, Cologne, Germany

Analysis of antibody-based myostatin inhibitors
M. THEVIS et al. / German Sport university, Cologne, Germany

Direct detection of homologous and autologous blood transfusion through immunorecognition of specific markers of blood storage. (Acronym: Hemab)
J. PASCUAL et al. / Fundació IMIM, Spain

In vivo metabolism studies on growth hormone releasing hormones and their detection by liquid chromatography-mass spectrometry
M. THEVIS et al. / German Sport university, Cologne, Germany

Exogenous DHEA administration and performance: Possible mechanisms of action and metabolic signature
K. COLLOMP et al. / Université Orléans, France

Impact of glucocorticosteroid administration on the steroid profile
R. VENTURA et al. / Fundació IMIM, Spain

Development of a two-dimensional HPLC method for the GC/C/IRMS analysis of corticosteroids and low concentrated urinary metabolites
C. AYOTTE et al. / INRS - Institut Armand Frappier, Canada

Mass Spectrometry, Quantification, Isotope-Dilution Internal PSAQ Standard
G. PICARD / Promise Advanced Proteomics, France

Development of intact hCG reference intervals in normal male urine samples for establishing a threshold value for doping control
A. BUTCH / UCLA Olympic Analytical Laboratory, USA

Development of a gas chromatography/mass spectrometry based method for the detection of xenon in human urine
W. SCHANZER / German Sport University, Germany

Application of High-Accuracy Reference Measurement Procedures for Target-Setting in WADA EQAS Programs for Longitudinal Steroid Profiling
E.J. MURBY et al. / National Measurement Institute, Australia

“Screening of testosterone misuse by metabolites resistant to enzymatic hydrolysis” and “Characterization, elucidation and synthesis of a potential marker for testosterone misuse”
O.J. POZO et al. / Fundació IMIM, Spain

Boosting the 15-nitric oxide sensitivity for total hemoglobin mass measurements using an optical cavity
R. GABLER / Invivo GmbH, Germany

Doping tests in special situations - low dose testosterone use and in post-conceptional period
A. RANE et al. / Commonwealth of Australia, Australia

Development of a synthetic reference material for a multiplex test panel for anabolic gene doping
A. BAOUTINA et al. / Commonwealth of Australia, Australia

Improved Detection of Difficult Analytes in Doping Control Analysis - Introduction of Supercritical Fluid Chromatography (SFC) as Orthogonal Technique
M. PARR et al. / FU Berlin – Pharmacy, Germany

Detection of recombinant human erythropoietins by liquid chromatography mass spectrometry
O. MASATO et al. / Mitsubishi Chemical Medience Corporation, Japan

Detection of prohibited substances by ultra-high performance supercritical fluid chromatography: Drawbacks and benefits for anti doping drug testing
R. NICOLO et al. / Swiss Laboratory for Doping Analyses, Switzerland

Development of ultra sensitive duplex differential immunoassays for detection of doping with insulin analogues
Z. WU / Charite Campus Mitte, Germany

Extension of the Athlete Biological Passport: Inclusion of the isotope mass spectrometric data
X. de la TORRE et al. / Federazione Medicio Sportiva Italiana, Italy

Pharmacological properties of procaterol in relation to competitive sport
V. BACKER et al. / Bispebjerg University Hospital, Denmark

Markers of fluid balance: Evaluating osmolality, albumin and blood lactate for the athlete biological passport
D. EICHNER et al. / Sports Medicine Research and Laboratory Testing, USA

Confirmation of formestane abuse in sports: A metabolic approach
X. de la TORRE et al. / Federazione Medico Sportiva Italiana,Italy

Impact of intense exercise on pharmacokinetics and pharmacodynamics of budesonide and methylprednisolone in relation to doping analysis
J. BANGSBO et al. / University of Copenhagen, Denmark

A new integrated approach for the sensitive and unambiguous detection of prohibited protein substances in biofluids
R. HASELBERG et al / VU University Amsterdam, The Netherlands

Enantioselective pharmacokinetics of formoterol and application to doping control
G. JACOBSON et al / University of Tasmania, Australia

Can the application of the anti-malaria drug proguanil lead to an adverse analytical finding for the diuretic agent chlorazanil?
W. SCHANZER et al / (Center for Preventive Doping Research, German Sport University, Germany) and Agence Française de Lutte contre le Dopage (AFLD)

Detection  of  Sotatercept (ACE-011,  ActRIIA-IgGI)  in  human  urine and blood – Protocols for initial and confirmatory doping testing
C. REICHEL et al. / Seibersdorf Labor GmbH, Austria

Optimization of SAR-PAGE for inclusion of peginesatide (Omontys, Hematide) in comprehensive electrophoretic ESA doping testing
C. REICHEL et al. / Seibersdorf Labor GmbH, Austria

Influences of Traditional Chinese Medicines Containing Endogenous Steroids on Doping Test
J. WANG et al. / China Anti-Doping Laboratory, China

Certified Internal Standard for Accuracy in Longitudinal Monitoring for Testosterone Abuse
S. DAVIES et al. / National Measurment Institute, Australia

Ultra-Sensitive Mass Spectrometric Detection of an rEPO Specific O-glycopeptide as an Unambiguous Proof of Doping (Acronym: GOpep)
J. PASCUAL et al. / Fundacio IMIM, Spain

Androgens and Contraceptives Steroids Interaction with ABP
A. RANE et al. / Karolinska Institutet, Sweden

The Long-Term Ergogenic Effect of Long Acting Beta-2-Agonists
J. DICKINSON et al. / University of Kent, UK

Characterization of the Urinary Metabolite Profile of Human Insulin by LC-MS/MS: A possible means to uncover Insulin Abuse
M. THEVIS et al. / German Sport University Cologne, Germany

Dried Blood Spots (DBS) in Sports Drug Testing: Complementary Matrix Providing Unique Features and Utilities to Modern Anti-Doping Fights
M. THEVIS et al. / German Sport University Cologne, Germany

A Secretagogue Chemiluminescent Assay
R. GALLEGO et al. / Fundacio IMIM, Spain

Novel Methods for Identification of Recombinant Glycoprotein Hormones Extension
M. UEKI et al. / Japan Chemical Analysis Center, Japan

Novel Approach to detect and identify low abundant long-term metabolites of prohibited drugs using GC/C/IRMS and HRMS
M. THEVIS et al. / German Sport University, Germany

Effects of snus administration on sport performance
C. CHIAMULERA et al. / University of Verano, Italy

Implementation of method of erythropoietin gene doping detection in WADA accredited laboratories
A. BAOUTINA et al. / Commonwealth of Australia (NMI) Australia

In vitro metabolism studies of selected synthetic cannabinoids
G. FORSDAHL et al. / Seibersdorf Laboratory GmbH, Austria

Clenbuterol in meat. Development of a decision model for the discrimination between contaminated meat and pharmaceutical preparations. Part 2
S. STERK et al. / RIKILT Wageningen, The Netherlands

Detection of the Long-Acting Testosterone Formulation Nebido and Influence on Blood and Steroid Profile Values
P. VAN EENOO et al. / Ghent University, Belgium

Investigation of in vitro/ex vivo TB-500 metabolism, synthesis of relevant metabolites and detection limits in urine and plasma
P. VAN EENOO et al. / Ghent University, Belgium

New challenges in insulin detection: Liposome-vehiculated insulins
F. BOTRE et al. / Federazione Medico Sportiva Italiana, Italy

Detecting autologous blood doping through the analysis of erythrocyte transcriptome
J. CHI et al. / Duke University, USA

Non-banned drugs as metabolic modulators: Effect of antifungals on the urinary steroid profile
M. MAZZARINO et al. / Federazione Medico Sportiva Italiana, Italy

Endogenous erythropoietin stimulation by CO-breathing and by stabilizing HIF-1 by oral Cobalt application
W. SCHMIDT et al. / University of Bayreuth, Germany

Evaluation of alternative glucocorticosteroid metabolites for the discrimination between legal and forbidden administration routes
R. VENTURA et al. / Fundació Institut Mar d’Investigacions Mèdiques (IMIM)

Enantioselective pharmacokinetics of salbutamol and application to doping control
G. JACOBSON et al. / University of Tasmania, Australia

Pharmacological properties of inhaled beta2-agonists in athletes with special emphasis on Salmeterol and Terbutaline
B. BACKER et al. / Bispebjerg University Hospital, Denmark

A System Biology Biomarkers Approach to the Differentiation of Recombinant Human Erythropoietin Doping from Confounding Factors
Y. PITSILADIS et al. / Brighton University, UK

New Engineered enzymes for sulfate ester hydrolysis to improve doping control
M. MCLEOD et al. / Australian National University, Australia

Investigating factors affecting stability of synthetic DNA reference material at frozen temperatures and optimizing conditions for improved stability
A. BAOUTINA et al. / Commonwealth of Australia (NMI) Australia

Profiling of minor metabolites and confirmation by IRMS
P. Van EENOO et al. / Ghent University, Belgium

Validation  of  a  novel  test  for  autologous  blood  doping: High altitude, gender and strenuous endurance exercise
C. MALM et al. / Umeå University, Sweden

Effect  of  tea  consumption  on  the  steroid  profile  in  healthy volunteers
R. VENTURA et al. /  Fundació  Institut Mar d’Investigacions Mèdiques (IMIM)

Study on the detection of dope testosterone manipulated with 13C labelled standards
J. WANG et al. / China Anti-Doping Laboratory, China

Synthesis of recently reported phase II metabolites for their inclusion in routine doping control analysis
O. POZO et al. / IMIM (Hospital del Mar Medical Research), Spain

Evaluation of sulfate conjugated metabolites to improve detection capabilities of the misuse of anabolic androgenic steroids
R. VENTURA et al. / IMIM (Hospital del Mar Medical Research), Spain

Dose-response effect of alcohol ingestion on steroid profile (Acronym: Profethyl)
R. de la TORRE et al. / IMIM (Hospital del Mar Medical Research), Spain

Detection of AICAR administration by carbon isotope ration mass spectrometry
M. THEVIS et al. / German Sports University, Germany

Masking strategies in sport doping: Modulation of phase II metabolism
M. MAZZARINO et al. / Federazione Medico Sportiva Italiana, Italy

a) A systems biology biomarker based approach to the detection of microdose recombinant human erythropoietin doping and b) Metabolomic profiling of recombinant erythropoietin in caucasian and east-African endurance trained athletes
Y. PITSILADIS et al. / University of Glasgow, UK

EPO signal peptides and the detection of recombinant EPO
C. PERMBERTON et al. / University of Otago, New Zealand

Two-dimensional liquid chromatography high resolution mass spectrometry screening method for peptide hormone in urine
C. GOEBEL et al. / NMI, Commonwealth of Australia, Australia

Pilot study: Evaluating the feasibility of erythropoiesis specific miRNA profiling for EAS doping detection in red blood cells
P. SIMON et al. / Johannes Gutenberg University, Germany

Epigenetic profiling to detect doping abuse
P. DIEL et al. / German Sport University, Germany

Nicotine, exercise and heat stress: Performance benefits, health risks and implications for the Prohibited List
T. MUNDEL et al. / Massey University, New Zealand

Development of a PSAQ-SRM assay to detect and quantify growth hormone and insulin-like growth factor 1
V. BRUN et al. / CEA/INSERM/UJF U1038, France

Rapid capillary electrophoretic detection of autologous blood transfusion
C. HARRISON / China Anti-Doping Laboratory, China

Application of metabolomic to doping controls-investigating alternative markers for testosterone and growth hormone abuse using mass spectrometry and biostatistics
M. THEVIS et al. / German Sports University Cologne, Germany

Stability of new markers and steroidomic model in steroid profiling
P. Van EENOO et al. / University of Ghent, Belgium

Effects of beta blockers on fine motor performance in archery
E. ERGEN et al. / World Archery Federation, Switzerland

The influence of exercise and dehydration on the pharmacokinetic and pharmacodynamic profile of beta2-agonists in various human populations
V. BACKER et al. / Bispebjerg University Hospital, Denmark

Detection of autologous DEHP-free blood transfusion using a combination of multiple biomarkers in different matrices
N. LEUENBERGER et al. / Swiss Laboratory for Doping Analysis, Switzerland

Detection of testosterone esters in blood sample
G. GMEINER et al. / Seibersdorf Labor GmbH, Austria

Improved steroids analysis employing the novel approach of regioselective anion attachment mass spectrometry
R. COLE et al. / Université Pierre et Marie Curie, France

Detection of autologous blood transfusions by flow cytofluorimetry: A multiparametric approach
F. DONATI et al. / Federation Medico Sportiva Italiana, Italy

Development of a rapid and sensitive detection of hGH-dependent serum markers based on fluorescence
G. KOEHLER et al. / MFPL, Austria

Longitudinal analysis on the detection parameters of endogenous AAS for target testing research
X. ZHOU et al. / China Anti-Doping Agency, China

Pharmacokinetics of inhaled salmeterol alone or in combination with fluticasone and investigation of the role of CYP3A4 and P-gp polymorphisms
M. PETROU et al. / Centre for Leisure Tourism and Sport Research and Development, Greece

Certified internal standards for accuracy in longitudinal monitoring for testosterone abuse
S. DAVIES et al. / Commonwealth of Australia, Australia

Stable isotope ratio analysis of nandrolone and boldonone preparations
C. GOEBEL et al. / Commonwealth of Australia, Australia

Proof of concept for the detection of clandestine compounds in urine samples using metabolomics
C. GOEBEL et al. / Commonwealth of Australia, Australia

Characterization of main metabolites of 17-methylstenblone and 17-methylmethonolone produced by human hepatocytes and liver fractions
C. AYOTTE / INRS-Institut Armand-Frappier, Canada

Production of a certified reference material of 19-norandrosterone to support GC/C/IRMS investigation of Adverse Analytical Findings for nandrolone
J. MURBY et al. / Commonwealth of Australia, Australia

GC/C/IRMS analysis of testosterone and nandrolone metabolites after the administration of testosterone enanthate and nandrolone decanoate in healthy volunteers
A. RANE et al. / Karolinska Institutet, Sweden

Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth
J. BRUNO et al. / Operational Technologies Corp., USA

Identification and detection of LH in urine
C. GOEBEL et al. / Commonwealth of Australia, Australia

Detection of circulating anti-Neu5Gc antibodies as a proof of use of recombinant glycoproteins: rEPO and analogues
J. PASCUAL et al. / Fundacio IMIM, Spain

Characterization and detection of prolonged Endothelin receptors antagonists administration
S. OSTOJIC et al. / Centre for Health, Exercise and Sports Sciences, Stari DIF, Serbia

Synthesis and in-vitro metabolism of sirtuins - a class of emerging drugs with misuse potential in elite sport
M. THEVIS et al. / German Sport University Cologne, Germany

Development of reliable blood tests for the detection of gene doping after intramuscular injection of recombinant adeno-associated viral vectors
R. SNYDER et al. / University of Florida, USA

Determination of red blood cell deformability in athletes during the course of the year: Considering gender, ethnic and training conditions
M. GRAU et al. / German Sport University Cologne, Germany

Characterization of main metabolites of 17-methylstenblone and 17-methylmethonolone produced by human hepatocytes and liver fractions
C. AYOTTE / INRS-Institut Armand-Frappier, Canada

Detection of doping with synthetic cannabinoids: Metabolic studies and in vitro generated reference material
G. FORSDAHL et al. / Seibersdorf Labor GmbH, Austria

Cardiovascular and central actions of drugs classed as stimulants
J.R. DOCHERTY / Royal College of Surgeons, Ireland

Carbon isotope ratio determination of seized nandrolone, boldenone and testosterone
C. SAGREDO et al. / Oslo University Hospital, Norway

Prenanalytical and analytical characterization of circulating micro RNA-144 for the detection of erythropoiesis-stimulating agent abuse
N. LEUENBERGER et al. / Swiss Laboratory for Analysis, Switzerland

Development of an analytical method for 19-norandrosterone, boldenone, and formestane in urine by on-line-coupling of LC-GC-MS and LC-GC-IRMS
J. VILLEN et al. / Doping Control Laboratory of Greece, Greece

Testosterone misuse: Evaluation of metabolites conjugated with glucuronic acid stable to hydrolysis with b-glucuronidase to improve detection capabilities
R. VENTURA et al. / Fundacio IMIM, Spain

Evaluation of solid phase microextraction for improved multi-residue extraction and analysis of Prohibited Substances by LC-MS/MS
J. PAWLISZYN et al. / University of Waterloo, Canada

Application of transcriptional and proteomic profiling to the detection of recombinant human Growth Hormone (rhGH)
B. GRAY et al. / Bond University Limited, Austrailia

Useful information about recently reported testosterone metabolites related with doping control analysis
J.O. POZO et al. / Fundacio IMIM, Spain

Clenbuterol in meat: A source for a positive doping control? Search for analytical strategy to distinguish abuse from meat contamination
S. STERK et al. / RIKILT Institute for Food Safety, Netherland

Detection of autologous blood transfusion by analysis of erythrocyte density fractions and flow cytometry
T. POTTGIESSER et al. / University Hospital of Freiburg, Germany

Trojan horses in blood doping: Can liposomes interact with haemoglobin, mask HBOCs or alter the haematological profile
F. BOTRE et al. / Federazione Medico Sportiva (FMSI), Italy

Novel methods for identification of recombinant glycoprotein hormones
M. UEKI et al. / Japan Chemical Analysis Centre (JCAC) Japan

Direct urinalysis of steroids
P. VAN EENOO et al. / DoCoLab Ugent, Belgium

AICAR: Determination of AICAR-ribotide in red blood cells as long term marker for an illicit AICAR application
M. THEVIS et al. / German Sport University, Germany

The influence of gender and race on the ergogenic and pharmacokinetic impact of lnhaled and oral terbutaline
G. WHYTE et al. / Liverpool John Moores University, UK

Statistical significance of hair analysis of clenbuterol to discriminate therapeutic use from contamination
D. THIEME et al. / IDAS Dresden, Germany

Detection of sulfo-conjugated anabolic steroids metabolites in antidoping initial and confirmatory analysis
E. LYRIS et al. / Doping Control Laboratory of Athens, Greece

Effects of glucocorticoid during repeated bouts of high-intensity exercise
M.C. DO et al. / Laboratory CIAMS, France

Long-term effects of Beta2-agonists on skeletal muscle characteristics, hypertrophy and exercise performance in healthy trained males and elite athletes
V. BACKER et al. / Bispebjerg Hospital, Denmark

Direct gene doping detection: Generation, characterisation and validation of a synthetic reference material for routine testing
A. BAOUTINA et al. / Commonwealth of Australia, Australia

Optimization of the synthesis of the chemical stabilization mixture of urine samples with simultaneous minimization of analytical matrix interferences
C. GEORGAKOPOULOS et al. / Doping Control Laboratory of Athens, Greece

Informatics, cross-study analysis and molecular signatures for the detection of doping
T. FRIEDMANN et al. / University of California San Diego, USA

Isoform specific tests to detect GH doping
M. UEKI et al. / Japan Chemical Analysis Center, Japan

Human androgen disposition - decisive determinants of variability
A. RANE et al. / Karolinska Institute, Sweden

Circulating MicroRNAs as stable biomarkers for detection of erythropoiesis-stimulating agent abuse
N. LEUENBERGER et al. / Laboratoire Suisse d'Analyse du Dopage, Switzerland

Identification of novel serum biomarkers for erythropoietin abuse: A proteomic approach
B. CHRISTENSEN et al. / Aarhus University Hospital, Denmark

A fair competition for the Growth Hormone Secretagogue receptor
R. GUTIERREZ-GALLEGO et al. / Fundacio IMIM, Spain

Biosensor-based detection of hepcidin as a new biomarker of erythropoiesis stimulators abuse
G. CAIRO et al. / University of Milan, Italy

Detection of illicit administration of human chorionic gonadotropin using immunoaffinity extraction and mass spectrometric detection
H. LUND et al. / University of Oslo, Norway

Potential of recently reported testosterone metabolites as markers for testosterone misuse in challenging cases
O.J. POZO et al. / Fundacio IMIM, Spain

Investigation on steroid profile alteration and metabolite excretion of the supplement ingredient androst-1-ene-3,17-dione for improvements of analytical result interpretation
M.K. PARR et al. / German Sport University, Germany

Degradation of urine samples and its influence on the 13C/12C ratios of excreted steroids
M. PIPER et al. / German Sport University, Germany

Detection of small interfering RNA (siRNA) as gene doping strategy using combined biochemical and mass spectrometric approaches
M. THEVIS et al. / German Sport University, Germany

Investigation on steroid profile alteration and metabolite excretion of the supplement ingredient androst-1-ene-3,17-dione for improvements of analytical result interpretation
M.K. PARR et al. / German Sport University, Germany

Hypothalamic-pituitary-gonadal axis feedback-Endocrine profiling as a supportive technique to detect abuse of anabolic, androgenic drugs including SARMs
P. DIEL et al. / German Sport University, Germany

Synthesis and analysis of the metabolites of several beta-blockers for doping control
J. YLI-KAUHALUOMA et al. / University of Helsinki, Finland

Protein target prediction for identifying molecules with performance-enhancing potential
J. MITCHELL et al. / University of St Andrews, UK

Enhancing the sensitivity of the 2D-PAGE detection assay for hGH doping: Follow-up study
M. THEVIS et al. / German Sport University, Germany

Test for blood transfusion (autologous/homologous) based on observed changes of Erythrocyte Membrane Protome
Z. NIKOLOVSKI et al. / University of Glasgow, UK

Characterization and detection of Growth Hormone releasing peptides and their metabolites using in-vitro and in-vivo approaches
M. THEVIS et al. / German Sport University, Germany

The impact of gender and race on the ergogenic and pharmacokinetic effects of chronic high dose short acting 2-Agonist use
G. WHYTE et al. / Liverpool John Moores University, UK

The use of cytochrome P450 inhibitors in sport: A new generation of doping masking agents
M. MAZZARINO et al. / Federazione Medico Sprotiva, Italy

Origin production of 19-norandrosterone in human urine samples and doping analysis
X. de la TORRE et al. / Federazione Medico Sportiva Italiana, Italy

Evaluation of human Cryopreserved Hepatocytes as an in vitro model for metabolism studies of doping agents
G. FORSDAHL et al. / Seibersdorf Labor GmbH, Austria

Ergogenic effects of high doses beta2-agonist on aerobic capacity, muscular power and recovery in health trained men
V. BACKER et al. / Copenhagen University Hospital, Denmark

Serum markers for parenteral application of testosterone preparations
G. GMEINER et al. / Seibersdorf Labor GmbH, Austria

Suitability of in competition testing in blood compared to urine matrix
N. BAUME et al. / Swiss Laboratory for Doping Analysis, Switzerland

Alternative steroid profiling: Part II
P. VAN EENOO et al. / University of Ghent, Belgium

Application of minimally-invasive method for mRNA sampling and addition of miRNA to the detection of r-HuEpo use by athletes
Y. PITSILADIS et al. / University of Glasgow, UK

Influence of renal flow rate on urinary concentration of compounds of interest to anti-doping agencies
R. MAUGHAN et al. / Loughborough University, UK

Subject-based profiling for the detection of lower dose testosterone administration in sport investigating the value of serum
A. KICMAN et al. / King's College London, UK

Exploring the potentials of transcriptomic and novel micro RNA screening approaches for the indirect detection of gene doping
P. SIMON et al. / University of Mainz, Germany

Development of standardized methods for determination of hCG in urine
U.H. STENMAN / Faculty of Medicine, Finland

Influence of athletes' hyperhydration on sample collection procedure in terms of urine pharmacokinetics of representative prohibited substances
C. GEORGAKOPOULOS et al. / Anti-Doping Laboratory, Doha, Qatar

Are liposomes masking agents? An investigation on the interaction between liposomes and anabolic steroids
F. BOTRE et al. / Federatione Medico Sportiva Italiana,Italy

Effect of Sildenafil on athletic performance in athletes with spinal cord injury: A prospective, placebo controlled, blinded, crossover study
S. WILLICK et al. / International Paralympic Committee, Germany

Pharmacogenomics of inhaled beta2-agonists and athletic performance
M. KOEHLE et al. / University of British Columbia, Canada

Stable isotope analysis of alkaloids and other biogenic amines relevant to doping control
W. SCHÄNZER / German Sport University, Germany

Influence of LH-RH application on urine and plasma levels of testosterone, LH-RH, LH and steroid profile
M. THEVIS et al. / German Sport University, Germany

Physiological and analytical factors affecting carbon isotope ratios of testosterone and androstanediols
W. SCHÄNZER et al. / German Sport University, Germany

Confirmation of differentially expressed genes associated with autologous transfusion
M. ASHENDEN et al. / SIAB Research Pty Ltd, Australia

The pharmacokinetics of repetitive doses of inhaled Salbutamol, Terbutaline and Formoterol and cardiorespiratory side effects of high doses of beta-agonists
V. BACKER et al. / Copenhagen University Hospital, Denmark

Educational external quality assessment scheme (EQAS) for the implementation of the finalized version of the isoform assays to detect GH doping in sports in WADA-accredited laboratories
M. BIDLINGMAIER / Ludwig-Maximilians-University, Germany

GH isoforms measured by the differential immunoassays in early and late pregnancy, in patients with pituitary diseases and diabetes
M. BIDLINGMAIER et al. / Ludwig-Maximilians-University, Germany

Pharmacological characterization of nucleosides as potential modulators of erythropoietin production and effects
P. A. BOREA et al. / University of Ferrara, Italy

Development of ultrasensitive DNA aptamer-based assays for natural and recombinant human Growth Hormone in serum and urine
J. BRUNO / Operational Technologies Corporation, USA

Yeast transactivation systems to support (routine) doping analytics
P. DIEL et al. / Deutsche Sporthochschule Köln, Germany

Detecting blood manipulation from total hemoglobin mass using 15-nitric oxide as tracer gas
R. GABLER et al. / INVIVO GmbH, Germany

Carbon isotope ratio determination and investigation of possible presence of manipulating substances in seized testosterone
G. GMEINER / Austrian Research Centers, Austria

Low molecular weight luteinizing hormone receptor agonists
C. GOEBEL et al. / National Measurement Institute, Australia

Detection of indirect androgen doping with a GnRH analog (leuprolide)
D. HANDELSMAN et al. / ANZAC Research Institute, Australia

Pharmacological manipulation of the central nervous system: Evidence of performance benefits and implications for the list of prohibited substances
R. MAUGHAN et al. / Loughborough University, UK

Determination of blood nicotine and cotinine concentrations before, during and after exercise performance
T. MUNDEL et al. / Massey University, New Zealand

Certified reference materials for accuracy in longitudinal monitoring for testosterone abuse
J. MURBY et al. / National Measurement Institute, Australia

Preparation and characterisation of new immunopurified urinary and plasmatic EPO standards. Acronym: REFEPOS
J. A. PASCUAL et al. / Fundacio IMIM, Spain

Experimental model for the study of the effects of platelet derived growth factors on muscles
F. PIGOZZI et al. / University of Rome “Foro Italico”, Italy

Implementation of HPLC/orbitrap mass spectrometry as a general screening method for doping control
G. RODCHENKOV et al. / Moscow Antidoping Centre, Russia

Development of urinary threshold levels for the detection of misuse of glycerol in sports
W. SCHÄNZER et al. / German Sport University, Germany

Detection of steroids by fast gas chromatography triple quadrupole tandem mass spectrometry (GC-QqQ)
P. VAN EENOO et al / Universiteit Gent-UGent, Belgium

Steroid metabolism & the chimeric mouse model
P. VAN EENOO et al. / Universiteit Gent-UGent, Belgium

Salbutamol metabolism: How to differentiate oral vs inhaled administrations: Looking outside the box
X. de la TORRE et al. / Federatione Medico Sportiva Italiana, Italy

AICAR determination of endogenous values to establish a threshold to distinguish exogenous administration
M. THEVIS / German Sport University, Germany

Optimization of the method for the detection of erythropoietin and its analogues
F. GARRIBBA / Federatione Medico Sportiva Italiana, Italy

Quantitation of hGH concentration in serum samples from top athletes with Caucasian and African origin in order to prove existing reference ranges
W. SCHÄNZER / German Sport University, Germany

Metabolism of anabolic androgenic steroids: Evaluation of sulfate conjugated metabolites to improve detection capabilities
R. VENTURA / Fundacio IMIM, Spain

Blood doping screening through capillary electrophoresis
C. HARRISON / San Diego State University, USA

Differentiation between the administration of the aromatase inhibitor Androstatrienedione, and the anabolic androgenic steroids Boldione and Boldenone
W. SCHÄNZER et al. / German Sport University, Germany

Precursor ion scanning for the detection of new steroids markers. Evaluation of population factors in the detectability of these markers. Routine application of precursor ion scanning for the open detection of anabolic steroids
J. POZO MENDOZA et al. / Fundacio IMIM, Spain

The impact of gender, race and hydration status on the ergogenic and pharmacokinetic impact of short acting β2-Agonists
G. WHYTE et al. / Liverpool John Moores University, UK

Storage contamination as a potential diagnostic test for autologous blood transfusion
M. ASHENDEN et al. / LSIAB Research Pty Ltd, Australia

Heparin: (more than) a masking agent in EPO-doping control
C. REICHEL et al. / Austrian Research Centers - ARC, Austria

Improving the traceability of steroid abuse by introduction of 2H/1H-analysis of urinary steroids
U. FLENKER et al. / German Sport University, Germany

Development Beta2 adrenoreceptor agonist and elite athletes pharmacokinetics, physiological and pharmacogenetic
V. BACKER et al. / Copenhagen University hospital Hormon Lab, Germany

Development of a method for the detection of doping with all forms of recombinant erythropoietins in human blood
C. REICHEL / Austrian Research Centers GmbH-ARC, Austria

Beta2-agonists: Modes of action and new tools for their detection
R. CANDAU et al. / Université Montpellier, France

Characterization of erythropoietin (EPO) produced in liver, a potential source to atypical EPO profiles in doping
Y. DEHNES et al. / Aker University Hospital, Norway

Precursor ion scanning for the detection of new steroid markers and the development of an LC-MS screening method for these markers
F. DELBEKE / Universiteit Gent-UGent, Belgium

Improvement of a Myostatin Imperacer assay towards a high-sensitive test system for the detection of anabolic manipulations, including gene doping strategies
P. DIEL et al. / German Sports University, Germany

Effects of anxiolytics on fine tuning (neuromuscular) activity performance
E. ERGEN et al. / FITA (International Archery Federation), Switzerland

Robustness of stable isotope analytical techniques in doping control
U. FLENKER / German Sport University, Germany

Genomic, proteomic and informatics analysis of doping
T. FRIEDMANN et al. / The Regents of the University of California, USA

Screening of designer steroids by NMR/pattern recognition
C. GEORGAKOPOULOS et al. / OAKA, Greece

GASepo software package
G. GMEINER / Austrian Research Centers GmbH - ARC, Austria

The effect of training, altitude exposure and athlete's sex on expression of genes know to change following autologous blood transfusion
C. GORE et al. / Australian Sports Commission, Australia

A holistic approach to (glycol) protein hormone doping analysis
R. GUTIERREZ GALLEGO et al. / Fundacio IMIM, Spain

Determination of the epitope specificity of anti-20 kDa antibodies by SPR – Search for complementary immunoglobulins, Acronym: 20-UP
R. GUTIERREZ GALLEGO et al. / Fundacio IMIM, Spain

Development of valid immunoassay methods for LH in urine
R. KAZLAUSKAS et al. / National Measurement Institute, Australia

Nanoparticles-based immunomagnetic extraction-capillary zone electrophoresis- native fluorescence detection: a novel strategy towards fast and cost-efficient detection of erythropoietin
Z. LIU et al. / University China, China

Improved detection of testosterone abuse
L. MACKAY et al. / National Measure Institute, Australia

Detection of autologous blood transfusion by proteomics: Screening to find unique biomarkers
C. MALM et al. / Umea University, Sweden

Skeletal muscle proteome alterations after long term anabolic steroid abuse
C. MALM et al. / Umea University, Sweden

Affinity-based biosensing (ABBs) for gene doping detection: An integrated approach
M. MINUNNI et al. / Universita degli Sutdi di Firenze Sesto, Italy

Detection of the non-human N-glycolyl- neuraminic acid (Neu5Gc) using immunopurification and chipLC/MS/MS. Acronym GLYCOCHIP
J. PASCUAL et al. / Fundacio IMIM, Spain

A gene microarray based approach to the detection of recombinant human erythropoietin doping in endurance athletes
Y. PITSILADIS et al. / University of Glasgow, UK

Detection of autologous blood transfusion using activated red blood cells (the red blood cells eNOS system)
P. PLATEN et al. / University of Bochum, Germany

Detecting blood manipulation from total hemoglobin mass – Minor or major confounding effects of injury, illness, long-lasting exercise, and maturation?
W. SCHMIDT et al. / University of Bayreuth, Germany

Sensitivity and specificity of a gene doping test detecting transgenic DNA on a single molecule level in peripheral blood probes
P. SIMON et al. / Medical University Clinic, Germany

Robustness of stable isotope analytical techniques in doping control
U. FLENKER / German Sport University, Germany

Development of a high through put reference method for multiplex analysis of biomarkers of Growth Hormone Abuse
P. TEALE et al. / HFL Ltd, UK

GH-2004 validation of novel assays for the GH marker approach in the detection of GH abuse in sport
R. HOLT. / University of Southampton, UK

Part of hGH project final validation for implementation of GH detection. Second step: Delay of transport. Third Step: Reproductibility of result between A and B sample depending on storage
M. SAUGY / Laboratoire Suisse d'Analyses du Dopage, Switzerland

Final validation for implementation of GH detection first step: Collection scenarios
M. SAUGY / Laboratoire Suisse d'Analyses du Dopage, Switzerland

Human androgen disposition - Decisive determinants of variability
A. RANE / Karolinska Institutet, Sweden

Development of a screening tool for Peptide Hormones Using Immunoaffinity Purification and LC-MS/MS
M. THEVIS et al. / German Sport University, Germany

Identification and Mass Spectrometric Characterization of Urinary Proteins other than EPO Binding to Clone AE7A5 Anti-Human EPO Antibody
C. REICHEL et al. / Austrian Research Centers GmbH-ARC, Austria

The use of Blood mRNA Technology to Detect Abuse with GH and IFG-I in Sport
R. HOLT et al. / University of Southhampton, UK

Nutritional Supplements - still a risk of Inadvertent Doping? An extended WADA follow up study of the International IOC Study from 2002
H. GEYER et al. / German Sport university, Germany

Development of a Reliable Blood Test for the Detection of Doping after Intramuscular Injection of Recombinant Adeno-Associated Viral Vectors
R. O. SNYDER et al. / University of Florida , USA

Characterization, Diagnosis and prevention of various microbiological contaminants in urine samples
J. APAJALAHTI et al. / Alimetrics Ltd, Finland

Identification/detection of novel anaemia drugs
M. ASHENDEN et al. / SIAB Research Pty Ltd, Australia

Development of detection method of hydrolysed rapid-acting insulin analogues in human urine by ion trap mass spectrometry
C. AYOTTE / INRS-Institut Armand Frappier, Canada

Pilot Project for a WADA Bioinformatics Core Facility
R. BHASKER / University of California, USA

Rapid affinity purification process of EPO form urine as pre-treatment step for the IEF EPO doping test
J. CARLSSON / Uppsala University, Sweden

Immunological detection of tetracosactide in serum for anti-doping control purpose
J. de CEAURRIZ et al. / Agence Française de Lutte contre le Dopage, France

Glucocorticoid and performance: Possible mechanisms of action
K. COLLOMP et al. / Laboratoire LAPSEP, France

Detection and stability of thiazide drugs
F. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Development and harmonization of direct urinalysis quantitative methods for threshold substances
F. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Development of analytical methods for the quantitative determination of beta-agonists and determination of detection times after therapeutic use
F. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Genomic, proteomic and informatics analysis of doping
T. FRIEDMANN et al. / University of California, USA

Derivatization of anabolic steroids for low concentration detection by LCMS in doping control analysis
C. GEORGAKOPOULOS / OAKA, Greece

Harmonisation of uncertainty calculations of the quantitative doping control analytical procedures
C. GEORGAKOPOULOS et al. / OAKA, Greece

Confirmation of doping with natural androgens by Isotope Ratio Mass Spectrometry: Simplifying the analytical procedure and increasing the evidential power
A.T. KICMAN et al. / King's College London, U.K

Development of tests for detecting hypoxia-inducible gene doping to enhance athletic performance
S. LAHIRI et al. / University of Pennsylvania, USA

Certification of steroid carbon isotope ratios in a freeze dried urine Certified Reference Material
L. MACKAY et al. / Commonwealth of Australia, Australia

Detection of autologous blood transfusion by proteomics: Screening to find unique biomarkers
C. MALM / Umea University, Sweden

Quantitative proteomics of rhGH-Doping by multiplexed stable isotope labeling and MALDI-TOF/TOF mass spectrometry
C. REICHEL et al. / Austrian Research Centers GmbH-ARC, Austria

Decreased pulmonary artery pressure by oral sildenafil ingestion at mild altitude and during exercise in air pollution increases exercise performance
K.W. RUNDELL et al. / Marywood University Scranton, USA

Identification and characterization of transcriptional markers diagnostic of autologous blood doping
J. RUPERT et al. / University of British Columbia, Canada

13C/12C analysis of urinary epitestosterone
W. SCHÄNZER et al. / German Sport University, Germany

Synthesis and characterisation of metabolites for the integration in a comprehensive screening procedure utilizing LC-MS/MS
W. SCHÄNZER et al. / German Sport University, Germany

Autologus blood transfusion detection through erythrocyte membrane proteome changes after blood storage
J. SEGURA et al. / Fundacio IMIM , Spain

Distinction between systemic and topic use of xenobiotic glucocorticoids in urine: Pilot Study Acronym: CORTICOTOPIC
J. SEGURA et al. / Fundacio IMIM, Spain

The effects of short-term use of inhaled salbutamol on anaerobic and aerobic exercise performance
B. SPORER et al. / Pacific Sport Canadian Sport Centre Vancouver, Canada

Fast analysis of insulin/c-peptide ratios in plasma as possible indicators for insulin misuse employing ELISA methods
M. THEVIS et al. / German Sport University, Germany

Synthesis and in vitro metabolism studies of selective androgen receptor modulators (SARMs) currently undergoing clinical trial (llb)
M. THEVIS et al. / German Sport University, Germany

Characterisation by surface plasmon resonance of monoclonal antibodies that address growth hormone isoforms
R. GUTIERREZ GALLEGO et al. / Fundacio IMIM, Spain

Synthesis of main metabolites of several aromatase inhibitors and antiestrogens as reference compounds for doping analytics
J. YLI-KAUHALUOMA et al. / University of Helsinki, Finland

13C/12C Analysis of urinary boldenone and its main metabolite in trace amounts
W. SCHÄNZER et al. / German Sport University, Germany

Metabonomic signature in bike athletes: A pilot study
Y. Le BOUC et al. / Hopital St Antoine, France

Chip technology for the detection of growth hormone abuse extension
R. GUTIERREZ-GALLEGO et al. / Fundacion IMIM, Spain

Hydropyrolysis as a preparative technique for compound-specific carbon Isotope ratio measurement of endogenous steroids
M. SEPHTON et al. / Imperial College, UK

Quantification of 19-Norandrosterone and 19-Noretiocholanolone Conjugates in plasma and urine samples by LC/MS/MS: Metabolic studies with nandrolone
C. SAUDAN et al. / Laboratoire Suisse d'Analyse du Dopage, Switzerland

Investigation of indirect markers of autologous blood transfusion in peripheral blood samples
M. ASHENDEN et al. / SIAB Research Pty Ltd, Australia

Determination of the origin of low urinary levels of 19-norandrosterone by GC/C/IRMS
C. AYOTTE / INRS-Institut Armand Frappier, Canada

Purification of EPO in urine samples prior to detection by Isoelectric focusing
C. AYOTTE et al. / INRS-Institut Armand Frappier, Canada

Metabolism of steroids via humanized livers in mice
F.T. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Prohormones: Market survey analysis, distribution and dissemination of information
F.T. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Advancement of the yeast transactivation system as a screening test for the structure independent identification of anabolic steroid misuse
P. DIEL et al. / German Sports University, Germany

hGH antibodies and kit development and production
A. ERNST / SphingoTec GmbH, Germany

Genetic variability, the urinary testosterone/epitestosterone ratio and anabolic steroids abuse
M. FINEL et al. / University of Helsinki, Finland

Can Sildenafil Improve Exercise Performance at Moderate Altitude?
A.L. FRIEDLANDER et al. / University of Miami, USA

Uniform calibration standards and methodology for GC-C-IRMS analysis of endogenous anabolic steroids
C. GEORGAKOPOULOS et al. / OAKA, Greece

Molecular Signatures of IGF-1 gene doping after AAV-Mediated gene transfer
M. GIACCA et al. / International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy

Proteomic analysis of serum exposed to GH: A future essay for detection of GH doping
J.O. JORGENSEN et al. / Aarhus University Hospital, Denmark

Development of tests for detecting Myostatin-based doping to enhance athletic performance
T.S. KHURANA et al. / University of Pennsylvania, USA

Development of antibodies to human asialo erythropoietin. Possible application to a confirmation procedure in anti-doping control of recombinant erythropoietin
F. LASNE et al. / Laboratoire National de Dépistage du Dopage, France

Development of an ELISA for Rapid Specific Detection of recombinant Erythropoietin and ARANESP (Darbepoetin alfa) in Biological Fluids
A.K. MURRAY / Glycozyme Inc. USA

Structural elucidation of the glycans present in human urinary EPO
J. A. PASCUAL et al. / Fundacio IMIM, Spain

Development of a web-based tool for the forensic evaluation of any longitudinal marker of doping
M. SAUGY / Laboratoire Suisse d’Analyses du Dopage, Switzerland

Identification and synthesis of a new long-term excreted metabolite of metandienone
W. SCHÄNZER / German Sport University, Germany

Long-term metabolites of 17 methylsteroids - investigation on 18-nor-17-hydroxymethyl 17 methyl-androstane derivatives
W. SCHÄNZER et al. / German Sport University, Germany

Quantification of 19-Norandrosterone and 19-Noretiocholanolone conjugates in plasma and urine samples by LC/MS/MS: Metabolic studies with Nanadrolone
C. SAUDAN et al. / Laboratoire Suisse d'Analyse du Dopage, Switzerland

Mass Spectrometric characterization and identification of endogenous and synthetic insulins
W. SCHÄNZER / German Sport University, Germany

Comparative gene expression profiling in human buccal epithelium and leukocytes after the abuse of beta-2-agonists and anabolic steroids
M. SCHONFELDER et al. / Technical Unviersity of Munich, Germany

IMAGENE: Non-invasive molecular imaging of gene expression useful for doping control: Extension study in animals after erythropoietin gene transfer
J. SEGURA et al. / Fundacio IMIM, Spain

Overall approach for blood transfusion detection (autologous/homologous)
J. SEGURA et al. / Fundacio IMIM, Spain

Sensitivity and Specificity of a gene doping test detecting transgenic DNA on a single molecule level in peripheral blood probes
P. SIMON et al. / Medical University Clinic Tubingen, Germany

A Pilot Study to Develop a Reliable Blood Test for the Detection of Gene Doping after Intramuscular Injection of Naked Plasmid DNA
R.O. SNYDER et al. / University of Florida, USA

Analysis of growth hormone isoform profiles in human plasma using proteomics strategies
M. THEVIS et al. / German Sport University, Germany

Organization and management of a proficiency test for homologous blood transfusion
M. SAUGY / Laboratoire Suisse d'Analyse du Dopage, Switzerland

The detection and confirmation of androstenediol abuse in athletes
R. KAZLAUSKAS et al. / Australian Sports Drug Testing Laboratory, Australia

Potential direct and indirect ergogenic effects of glucocorticoids
K. COLLOMP et al. / Université d'Orleans, France

Investigation into metabolism and detection in urine of new substances specified in the WADA 2005 List
R. KAZLAUSKAS et al. / Australian Sports Drug Testing Laboratory, Australia

Development of membrane assisted isoform immunoassay for rapid detection of rhEPO in doping
J. CARLSSON et al. / Uppsala University, Sweden

Alternative steroid profiling
F. T. DELBEKE et al. / Universiteit Gent-UGent, Belgium

High sensitive detection of genetically and pharmacological manipulations of the myostatin signal transduction pathway by multiplex immuno PCR fingerprint analysis
P. DIEL et al. / German Sports University, Germany

Effects of exhaustive exercise on endogenous production of steroid hormones (nandrolone, DHEAs and testosterone) in females
B. DUGUE et al. / University of Poitiers, France

Stabilization of urine and blood in the doping control sealed containers after the addition by the kit manufacturers of stabilization agents
C. GEORGAKOPOULOS / OAKA, Greece

Application of microarray technology for the detection of changes in gene expression after doping with recombinant hGH - part 2
G. GMEINER et al. / ARC Seibersdorf Research GmbH, Austria

Bitter-sweet differences between native and recombinant glycoprotein hormones - application to anti-doping strategies
R. GUTIERREZ GALLEGO et al. / Municipal Institute of Medical Research Foundation, Spain

Detection of growth hormone doping by gene expression profiling of peripheral blood cells in humans
K.K. HO et al. / Garvan Institute of Medical Research, Australia

The development of a methodology for detecting abuse with IGF-I in sport
R.I.G. HOLT et al. / University of Southampton, UK

Understanding of microbiological processes in doping control
A. LEINONEN et al. / United Laboratories Ltd. Finland

Production of testosterone/epitestosterone (T/E) certified reference materials in urine and solution
L. MACKAY et al. / Commonwealth of Australia, Australia

AR.I.E.T.T.A artificial intelligence evoking target testing in anti-doping
F. MANFREDINI et al. / International Biathlon Union, Austria

Rapid screening (and confirmatory) method for rEPO and NESP based on immuno-recognition of its exogenous N-glycolylneuraminic acid content
J. PASCUAL et al. / Fundacio IMIM, Spain

Development of a prototype blood-based test for exogenous erythropoietin activity based on transcriptional profiling
J. RUPERT et al. / University of British Columbia, Canada

Combined screening on diuretics and heavy volatile nitrogen containing doping substances, investigations on the metabolism and synthesis of phase II metabolites
W. SCHÄNZER et al. / German Sport University, Germany

Monitoring total hemoglobin mass (tHb)-the target parameter of endurance athletes-to detect blood manipulation
W.F.J. SCHMIDT et al. / University of Bayreuth, Germany

Qualitative and Quantitative Determination of Insulin like Growth Factor-I (IGF-I) or Synthetic Analogues in Human Plasma
M. THEVIS et al. / German Sport University, Germany

Synthesis of mesocarb metabolites as reference compounds for doping analytics
J. YLI-KAUHALUOMA / University of Helsinki, Finland

Detection of recombinant human LH as doping agent
D.J. HANDELSMAN et al. / ANZAC Research Institute, Australia

Development and application of a tight bioassay - based control system for steroids and other prohibited substances in sports doping analysis
E. SONNEVELD et al. / BioDetection Systems B.V. The Netherlands

Prevalence of the exercise-induced bronchoconstriction using the mannitol test, insight into potential ergogenic and deleterious effects of beta-2 agonists
R. CANDAU et al. / Université de Montpellier, France

Metabolism of "new" anabolic steroids: Development of in vitro methodology in metabolite production and analytical techniques
T. KUURANNE et al. / United Laboratories Ltd, Finland

Development of a universal screening procedure for acidic, neutral and doping agents in urine
A. LEINONEN et al. / United Laboratories Ltd, Finland

Characterisation of chemical and pharmacological properties of steroids of related to doping of athletes
C. AYOTTE / INRS-Institut Armand Frappier, Canada

Evaluation of membrane-assisted isoform immunoassay (MAIIA) for direct detection of rhEPO in doping
J. CARLSSON et al. / Uppsala University, UK

Criteria setting for the misuse of glucocorticosteroids: Study LNDD-Paris
J. DE CEAURRIZ et al. / Laboratoire National de Dépistage du Dopage (LNDD), France

Criteria setting for the misuse of glucocorticosteroids. Study LSDD-Lausanne
M. SAUGY & L. MATEUS-AVOIS / Laboratoire Suisse D'analyse du Dopage, Lausanne, Switzerland

Development of pharmacological in vitro test systems for the structure independent identification of anabolic substances
P. DIEL et al. / German Sport University, Germany

Application of time-of-flight mass spectrometry for the unification and expansion of the window of screening methods of the WADA laboratories
C. GEORGAKOPOULOS et al. / OAKA, Greece

Bioassay-based screening and detection of novel designer androgens
D.J. HANDELSMAN et al. / Research Institute Concord Hospital, Australia

Improved methodology for detecting and confirming the abuse of glucocorticosteroids
R. KAZLAUSKAS et al. / Australian Sports Drug Testing Laboratory, Australia

Determination of inter-day variations in hGH markers in athletes
A. KNIESS / Institute of Doping analysis and Sports, Germany

Endocrine study on the effects of testosterone gel application in male athletes
P. PLATEN et al. / Institute of Cardiology and Sports Medicine, Germany

The application of cellular chemistry and proteomic approaches to the detection of gene doping
J. ROBERTS et al. / HFL Ltd, UK

Study of a new procedure to detect haemoglobin-enhancing substances or methods that improve oxygen transfer
P. SALLET / Audirep, Groupe d'Etudes Marketing, France

The detection of the misuse of testosterone gel
W. SCHÄNZER et al. / German Sport University, Germany

Mass spectrometric characterization and identification of endogenous and synthetic insulins
W. SCHÄNZER et al. / German Sport University, Germany

Development of methods for the detection of the misuse of the aromatase inhibitors anastrozole, letrozole and vorozole in urine
W. SCHÄNZER et al. / German Sport University, Germany

Detection of doping with 1-Testosterone
M. WU / National Research Institute of Sports Medicine, China

Metabolism and excretion of 3,6,17- Androstenetrione
F. DELBEKE et al. / Universiteit Gent-UGent, Belgium

Microarray detection methods for GH and IGF-1
T. FRIEDMANN et al. / University of California, USA

Implementation of isoform-based GH test in 3 WADA-accredited laboratories
M. BIDLINGMAIER et al. / Klinikum der Universitaet, Germany

Application of microarray technology for the detection of changes in gene expression after doping with recombinant Human Growth Hormone
G. GMEINER et al. / ARC Seibersdorf Research, Austria

GASEPO2- A software tool for analysis of EPO images after isoelectric focusing and double blotting
Dr. G. GMEINER et al. / ARC Seibersdorf Research, Austria

The improved detection of recombinant erythropoietin in urine using immunoaffinity chromatography
R. KAZLAUSKAS et al. / Australian Sports Drug Testing Laboratory, Australia

The dose of inhaled beta2-Agonists on athletic performance in non-asthmatic elite athletes: Competitive or statistical significance?
D.C. McKENZIE et al. / University of British Columbia, Canada

Influence of changes in diet on the dynamics of 13C/12C in selected urinary steroids
W. SCHÄNZER et al. / German Sport University, Germany

The effects of factors such as exercise and disease on the distribution of urinary erythropoietin isoforms
R. KAZLAUSKAS et al. / Australian Sports Drug Testing Laboratory, Australia

Development of a proteomic technology platform for the generic detection of protein drugs in sport
N. PACKER et al. / Proteome Systems Ltd, Australia

Detection of doping with Ghrelin – Determination of blood profiles and urinary excretion, and stimulation of GH release after intravenous injection in athletes
P. PLATEN / German Sport University, Germany

Conversion of 4-Norandrostenedione, 4-Norandrostenediol and 5-Norandrostenediol to Nandrolone in Human Subjects
W. SCHÄNZER et al. / German Sport University, Germany

Investigation about the defects and the detection of finasteride, a substance which can be misused as masking agent in doping control
W. SCHÄNZER et al. / German Sport University, Germany

Chip technology for the detection of growth hormone abuse
J. SEGURA et al. / Fundacio IMIM, Spain

GH-2004: The development of a methodology for detecting abuse with growth hormone in sport
P. SÖNKSEN et al. / University of Southampton, UK

Mass spectrometry of peptide hormones
G. J. TROUT et al. / National Measurement Institute, Australia

Development of solution and urine matrix CRMs for the detection of steroid doping
S. WESTWOOD et al. / National Measurement Institute, Australia

Endogenous testosterone, testosterone precursors and metabolites: 19 Nor-steroids and establishment of normal urinary levels of these related compounds
E. Al-DUJAILI / Queen Margaret University College, Scotland

Detection of oxygen delivery enhancers using dual detection methodology
M. J. ASHENDEN et al. / SIAB Research Consortium, USA

Analysis of 19-Norsteroids, testosterone and precursors metabolites in human urine by CG/C/IRMS
C. AYOTTE et al. / INRS - Institut Armand-Frappier, Canada

Excretion of 19 Nor-steroids from consumption of pork meat and offal: Combined GC/MS and GC/C/IRMS analysis
C. AYOTTE et al. / INRS - Institut Armand-Frappier, Canada

Pharmacokinetics of pharmaceutical testosterone and T/Es in subjects with low and high baseline T/Es: Assessment of the ethnic differences and of the sensitivity of various carbon isotope ratio methods relative to T/E
D. H. CATLIN et al. / UCLA Olympic Analytical Laboratory, USA

Human androgen metabolism, kinetics and excretion - Genetic and ethnic determinants of variation
M. GARLE et al. / Karolinska Institute, Sweden

Manipulation of muscle mass vs the growth hormone/insulin-like growth factor axis
G. GOLDSPINK et al. / Royal Free and University College Medical School, UK

Androgen/growth factor study in young (AGSY)
C. HAGEN, et al. / Odense University Hospital, Denmark

Studies related to the metabolism of endogenously produced nandrolone and exogenously administered nandrolone precursors
P. HEMMERSBACH et al. / Hormone Laboratory University Hospital, Norway

Defining interaction between anabolic and peptide hormones requirements for a robust test for growth hormone doping
K. HO et al. / Pituitary Research Unit, Institute of Medical Research, Australia

Ghrelin: A newly discovered growth hormone stimulating peptide
J. O. JORGENSEN / Aarhus university Hospital, Denmark

Detection of the abuse of haemoglobin-based blood substitutes in sport
R. KAZLAUSKAS et al. / National Measurement Institute, Australia

Detection of rEPO abuse in athletes
M. MAGNANI et al. / Institute of Biochemistry "G.Fornaini", Italy

An immediate implementation of a realistic strategy against rhEPO doping: Two indirect blood parameters used for screening and a direct detection of rhEPO in urine for confirmation
P. MANGIN et al. / Laboratoire Suisse D'analyse du Dopage, Switzerland

Unequivocal confirmation of recombinant erythropoietin (rhEPO) in human urine through structural evidences of specific glycosylation
J. PASCUAL et al. / Fundacio IMIM, Spain

Detection and identification of plasma volume expanders based on polysaccharide structures in human urine combined with the analysis of the diuretic mannitol
W. SCHANZER et al. / German Sport University, Germany

Development of a test method to detect growth hormone abuse in sports
C. J. STRASBURGER et al. / Charité Campus Mitte, Germany

Production of pure substance CRMs for the detection of doping with testosterone precursors and 19 Nor-steroids
S. WESTWOOD / National Measurement Institute, Australia